A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacyBrent A. Williams, Armand Keating, Arjun Law et al.|Oncotarget|2017Cited by 187
Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological MalignanciesArjun Law, Auro Viswabandya, María Queralt Salas et al.|Biology of Blood and Marrow Transplantation|2018Cited by 92
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHDMaría Queralt Salas, Auro Viswabandya, Shruti Prem et al.|Bone Marrow Transplantation|2020Cited by 59
Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent FormatsBrent A. Williams, Armand Keating, Arjun Law et al.|Journal of Clinical Medicine|2019Cited by 58
Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantationMaría Queralt Salas, Rajat Kumar, Shabbir M.H. Alibhai et al.|Bone Marrow Transplantation|2020Cited by 43